Recruiting

Observational Study

Sponsor:

Icahn School of Medicine at Mount Sinai

Code:

NCT07455201

Conditions

Intracerebral Hemorrhage

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DynaCT Multiphase

DynaCT Sine Spin

Study Details

Brief summary:

The aim of the project is to collect pre-procedural CT scans, intra-procedural post-evacuation scans as well as immediate post-procedural CT scans to evaluate and collect feedback of two Siemens prototypes: 1) perfusion prototype and 2) automatic hemorrhage detection prototype. The assessment of the prototypes, including its features will focus on the feasibility, usefulness as well as the potential clinical value add in minimally invasive ICH treatment.

Conditions

Intracerebral Hemorrhage

Study ID

NCT07455201

Start date

Oct 31, 2025

Status verified date

May, 2026

Completion date

Dec 31, 2028

Anticipated

Primary completion date

Dec 31, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patient ≥ 18 years old
  • Patient is planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital

Exclusion Criteria:

  • Patient is < 18 years old
  • Patient is not planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital

Study Design

Enrollment

15 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

other: DynaCT Multiphase scan

All enrolled patients will undergo an extra DynaCT Multiphase scan.

Interventions

DynaCT Multiphase

DynaCT Multiphase device is the perfusion prototype scan. DynaCT Multiphase scans taken intra-operatively will be processed offsite on Siemens' hemorrhage detection and perfusion prototypes.

DynaCT Sine Spin

DynaCT Sine Spin scan is the automatic hemorrhage detection prototype. Scans taken intra-operatively will be processed offsite on Siemens' hemorrhage detection and perfusion prototypes.

Primary outcome measure

  • Volume of Post-procedure hemorrhage [ Time Frame: Immediately post-procedure ]

Central Contacts and Locations

Central contacts

Emily Svendsen

212-241-3238Emily.Svendsen@mountsinai.org

Sydney Edwards

(212) 241-2524Sydney.Edwards@mountsinai.org

Locations

Mount Sinai West

Recruiting

New York, New York, United States, 10019

Principal Investigator:

Christopher Kellner

More Information

Sponsor

Icahn School of Medicine at Mount Sinai

Last update posted

May 6, 2026

Last verified

May, 2026

Keywords

  • Minimally invasive hemorrhage evacuation

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai on 2026-05-06.